Form 4: Roivant Sciences Director Keith Manchester Sells Shares
SEC Form 4 Filing
Director Keith Manchester of Roivant Sciences Ltd. sold a portion of his common shares in two transactions on September 24 and 25, 2024.
Summary
- Keith Manchester, a director of Roivant Sciences Ltd., reported changes in beneficial ownership.
- On September 24, 2024, Manchester sold 368,052 common shares at a price of $11.625 per share.
- Following this transaction, Manchester directly owned 1,412,126 common shares.
- On September 25, 2024, Manchester sold an additional 134,948 common shares at a price of $11.7653 per share.
- After the second transaction, Manchester directly owned 1,277,178 common shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting the sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but the market may react based on their interpretation of the sale.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes.
Key Dates
| Date | Description |
|---|---|
| 09/24/2024 | Keith Manchester sold 368,052 common shares at $11.625 per share. |
| 09/25/2024 | Keith Manchester sold 134,948 common shares at $11.7653 per share. |
| 09/26/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.